Effects of Metabolites of Lactobacillus casei on Expression and Neutralization of Shiga Toxin by Enterohemorrhagic Escherichia coli

Arpita Aditya,Zajeba Tabashsum,Zabdiel Alvarado Martinez,Debabrata Biswas
DOI: https://doi.org/10.1007/s12602-024-10212-8
2024-01-16
Probiotics and Antimicrobial Proteins
Abstract:Shiga toxin ( stx ), produced by enterohemorrhagic Escherichia coli (EHEC) or Shigella , causes hemolytic uremic syndrome (HUS) in humans. EHEC-mediated illnesses are recommended to treat by immune supportive strategies, instead of antibiotic therapy. Widely used probiotic Lactobacillus casei produces many bioactive metabolites, i.e., conjugated linoleic acids (CLAs) which have potential to educate host immunity and control EHEC growth and expression of its virulence genes. In this study, it was found that total metabolites of L . casei exerted a protective effect on Gb 3 receptor containing mammalian cells against stx exposure.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?